Genzyme Joins International Initiative to Help Develop Malaria Drugs

Oct 19, 2006

NEW YORK (GenomeWeb News) — Genzyme will join an international public/private initiative to develop malaria drugs, the company said yesterday.

The company will work with the Medicines for Malaria Venture, MIT’s Broad Institute, and Harvard University to develop treatments by identifying compounds that the company claims offer a new approach to treating the disease.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Years and Years

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Diving Evolution

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

This Week in Science

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

Issues to Overcome

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Main menu